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The sites in ~ukaryolic elongation factor eEF-2 phosphorylated by the Ca~*tcalmodulin.depcnd¢nt ZF.2 ktnas© in vitro have been identified, The 
kinase atalysed the rapid mcorperation of one real ol'phosphate par real cEF.2 .nd the slower incorporation ofa second mol. All the phosphorylation 
sit,:s in eE F-2 are contained in the CN Br fragment ¢orrespondinil to residues 22~ 155. TP/ptie discstion cf phosphorylnted QEF.2 yielded 3 phospko- 
peptides, one being tlnique to monophosphoryl~ted eF.F.2, The phosphorylation sites w©re identified as threonine residues 56 and 58. tha fona~r 
bein8 more rapidly phosphorylated, Ala.Gly.Glu-Thr.Phc-Th#*-Asp.Thr'~.Arl~. The same sites are labelled in eEF-2 isolated from reticulocyte 
lysates, 
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1. INTRODUCTION 
It is now well established that translation in mam- 
malian cells is regulated via sevc~'al distinct mechanisms 
which include the phosphorylation of elongation 
factor-2 (eEF-2) [1-5]. eEF-2 (a monomeric protein of 
100 kDa) mediates the translocation step o f  peptide. 
chain elongation. It is phosphorylated on threonine 
residues by a specific eEF-2 kinase, (previously termed 
Caa+/calmodulin.dependent protein kinase III [3,4]) 
and its phosphorylation is increased in intact ceils in 
response to stimuli which increase intracellular 
Ca z÷'ion concentrations [6-13]. Phosphorylation of 
the endogenous eEF-2 impairs the translation of mRNA 
in the reticulocyte lysate celt-free system [5] and several 
other lines of evidence show that phosphorylated EF-2 
is inactive, or has only low activity [3,4, 14,15]. 
There have been varied reports on the stoichiometry 
of eEF-2 phosphorylation i  vitro. These range from 
about one mol phosphate per mol eEF-2 [3], through 
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"The numbering is based on the sequence of eEF-2 itself rather than 
the open reading frame: the initiator methionine residue is absent 
from the mature protein [17-19] 
two [16] to three mo~, phosphate per mot eEF-2 
(reported in [!]). The work of Nairn and Palfrey [3] 
suggested that at least some of the phosphorylation sites 
in eEF-2 were located in the threonine-rich region be- 
tween residues 50 and 60. We now show that in vitro 
two real of phosphate can readily be incorporated into 
eEF-2, and that the residues labelled are threonines 56 
and 58* We also demonstrate that the same sites are 
phosphorylated in reticulocyte lysates. 
2. MATERIALS AND METHODS 
2, I. Material, s 
These were obtained as described previously [20]. eEF-2 ancl its 
kinase were prepared as described previously [21], 
2.2. Phosphorylation feEF-2 
eEF-2 (200 ,g) was incubated with eEF-2 kinase in the presence of 
20 mM (N-[2-hydro>cyethyll-piperazine-N'-[3-propane-sulphonic 
acid]) pH 7,6, 125 .aM ATP, 10 mM MgCI2, 10 ~g, ml -~ of 
calmodulin, 0,15 mM CaClz, and 10 #Ci of [3,-3~PIATP in a final 
volume of 250 ~1 at 30°C. The amount of kinase used in preparative 
experiments incorporated 1 real of phosphate per real of eEF-2 within 
1 rain, Lower amounts of kinase were used in some other experiments 
(see section 3), Proportionately smaller scale phosphorylations were 
performed for ocher analyses. 
Samples were taken at various time points for SDS-PAGE, for 
isoelectric focusing (IEF) (see below), or for other analyses where 
phosphorylation was terminated by addition of an equal volume of 
ice-cold 20070 trichloracetic acid, The pellet was recovered by een- 
trifugation and washed with ice-cold 10070 trichloracetic acid. follow- 
ed by ice-cold acetone (eEF-2 had previously been determined to be 
the only phosphoprotein present), 
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2.~, gD$.pol,~ucrMmnldv ltet elc¢ltvph#r¢~i:~ andhoct¢¢trW foct~#taN 
SDS.PAGI~. w~t~ performed ,tde~¢rlbed [201. One.dimensional Hab 
I[{F w~ perf0rmgd e~,~enlialty n~ described 1221 t~,~tn~ itel~ t0.'t$ mm 
thick) ¢ontalntnli 9 N1 urea (enzyme llr~de, Betlte~da Research k~b,~., 
hiD, U.S,A,), 4 ,~ (w,~v) agrylamld~, 0,2% (w/v) bt~.agrylamtd~ 
nnd 3.$% [v/v) ~mpholyte~ [pti r~,nlle~t 3-/0 and 7.9 mi~ed In a ratio 
of I;4, Ph~,rmada.LKB, Upp~ala, Sweden] 
2.4, CNBr diRe#lion, redl~¢llan and e#¢bo.t'icJttomclh.vl#flon 
Pre¢ipitated eEF.2 or eEF.2 in ghip~ ex¢i.~ed front IffF gd~ war 
digested with CNBr [2~1. The elu,nt wa~ removed and the ~hips were 
estracted several tirne~ with 70~ ferrule acid. The sm~tple,~ were then 
dried down in a Speedvac centrifuged evaporator (Savant. Higk~villel 
N¥) and extensiv©ly w=tshed whh waler. The gel derived ¢lige~t~t were 
redisSolved in O.I % (w/v] SDS and rite Coomas~ie blue stain and SDS 
removed by acetone precipitation or the peptidgs [201. Tl~e pepthles 
were redissolved in 50#1 of 0,4 M ammonium bicarbonate (pII 8,2) 
containing 8 M urea and reduced and garboxiodomethylated a~ 
(le~eribed [24]. The products were analysed by trleine SD$.PAOE 12~] 
ndapted for a mini.gel system 1201. Ahernativety, zl~e reaction was ter- 
minated by direct injection onto a reverse.phase HPLC colurnn (~ee 
below). After washing with solvent A to remove the ure,'t, Ihe 
ratliolabdled peptide(s) were eluted with 100% solvent B and dried 
do~n. 
2,L: Ptoreinase digestion and two.dimensionol pepttde mapping 
Digestions were carried out at 30'~C in a final volume of 25 td 0,1 
M ammonium bk:arbonate, pH 8,3 rot 2 h, using 10 t,8 of trypsin, 
followed by overnight incubation with a second identical doseof tryp- 
sin. Digestions with Asp-N proteinase were performed as described 
previously [23]. Two.dimenslonal peptide mapping comprising dice. 
trophoresis at pH 3.6 and thin-layer chromatography was performed 
as described earlier [201, 
2,6. Reveme-plJase chromatography 
Reverse-phase HPLC was performed as previously described [23] 
using a linear gradient of 0 to 10% solvent B over 50 rain (solvent A: 
0,1% trifluoroacetic acid in water, solvent B: 0,1o10 trifluoroacetic 
acid in acetonltrlle), Phosphopeptides for sequencing were 
rechromatographed un er the same conditions with a shallower gra- 
dient (0 to 5°70 B over 50 rain), or using 10 mM ammonium acetate in 
place of 0,107o trifluoroacetic acid as solvent A. 
22, Amino acid sequence analysis and identification of labelled 
phosphothreonine residues 
Peptides were sequenced using an Applied Biosystems 470 or 477A 
gas-phase sequencer with an on-line phenylthiohydantoin analyser. 
Phosphorylated residues were identified essentially as described [26], 
except that samples were loaded onto I mm 2 pieces ofprecycled glass- 
fibre disc, and these were in turn placed over an intact disc, such that 
reagent flow first encountered the disc pieces, Pieces were removed 
after the appropriate degradation cycle and the radioactivity was 
duted with 50°7o formic acid. The presence of 3zp label in phosphate 
or peptides was distinguished by electrophoresis at pH 3,6 [20] or at 
pH 1,9 [23]. 
3. RESULTS AND DISCUSSION 
3.1. Stoichiometry and time course o f  phosphorylation 
The chips f rom an SDS-polyacry lamide gel cor- 
responding to eEF-2 were excised and counted for 32p. 
radioact iv i ty (Fig. 1). One  mol of phosphate was rapid- 
ly incorporated  (within 4 rain under  these condit ions) 
and phosphory la t ion  more slowly reached a value of  2 
reel phosphate  per mol  of eEF-2 after about  one hour. 
The precise react ion kinetics clearly depend on  the 
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Fig, 1 ; Time course of phosphorylation f eEF-2 in vitro as analysed 
by SDS.PAGE. Panel A: autoradiograpt~ of an SDS.polyacrylamide 
gel of eEF-2 incubated with eEF-2 kinase and [~,-azP]ATP for the 
times shown (in minutes). The incubation conditions are gtven in sec- 
tion 2. The labelled arrow shows the position of eEF-2, Panel B: tl~e 
chips correspondir~g to eEF-2 from a similar experiment tothat slaown 
in Panel A were excised from the gel and counted for a2p radioactivi- 
ty. The results are e~pressed asreel P incorporated per reel eEF-2, 
amount  of kinase added, but  in all cases the first tool of 
phosphate  was incorporated 10-20 times faster than the 
second,  and  longer incubat ion produced no signif icant 
further  increase in phosphory lat ion.  
These f indings were independent ly  verified by ex- 
amin ing  the time course of phosphory lat ion on an IEF 
gel to resolve forms of eEF-2 which differ in their 
phosphory la t ion  state (Fig. 2). Two species more acidic 
than  untreated eEF-2 appeared within 15 rain. By 60 
min ,  nearly all the eEF-2 had been conver ted  to the 
most  acidic species. In preparat ive  xperiments using 
more  kinas¢ (see section 2), complete convers ion to the 
most  acidic species occurred within 10 min;  The three 
species were evenly spaced on the IEF  gel and 
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Fill. 2, Time course or pho~phorylation r eEF.2 in vitro =~ all~tly~¢d by isodcetri¢ rocu~tnlil, A similar ineubalto=~ to (hal in Fill, t was anal~'sed 
by i~aelcctri¢: ro¢,t~i.=, Samples of ~=P.l=lbclletl CLEF-2 were taken =It the limes Indicated and subje~:ted to IEF. Tile fitture show.~ an autoradiograph 
or tile re~uhin8 sel, Tit= positions of unphosphorylated eEF.2 (OP) and mono. and bisphosphoryla¢cd forms ot" ¢EF.2 (IP and 2P, respectively) 
are indicated, P=lnd~ A ~lnd B show, respectively, tile Coomassie bluc,st~incd Bel and the corresponding au(oradioliraph. 
presumably represented the non-phosphorylated and 
mono- and bisphosphorylated forms of eEF-2, These 
findings confirm the data in Fig. 1. 
These findings are in disagreement with Nairn and 
Palfrey [3] who reported a value of 1 tool. tool" t, and 
with Ovchinnikov et al. (reported in [1]) who found 3 
tool. tool- = 
3.2. Identification of phosphopeptides 
Phospl~oamino acid analysis revealed that only 
phosphothreonine was present in bisphosphorylated 
eEF-2, consistent with all the previous work on this pro- 
tein (not shown). A CNBr digest of phosphorylated 
eEF-2 gave a single radiolabelled fragment with an ap- 
parent Mr of 14.5 kDa on tricine SDS-PAGE (Fig. 3A). 
This must correspond to the largest CNBr fragment 
(residues 22-155), since no other fragment is larger than 
about 11.5 kDa (residues 497-603). It should be noted 
that although the sequence of rabbit eEF-2 used here, is 
not known, the three known mammalian eEF-2 se- 
quences contain methionines at the same positions 
[17-19]. Thus, all the label in bisphosphorylated eEF-2 
is located within residues 23-156 of its sequence. 
To locate the phosphorylation sites, this CNBr frag. 
meat was subjected to tryptic digestion, after carbox- 
iodomethylation to block cysteine residues. Two- 
dimensional maps of tryptic digests of 
monophosphorylated eEF-2 obtained from an IEF gel 
gave a single radiolabelled peptide (Fig. 3B) (peptide C, 
nomenclature based on the order of elution from 
reverse-phase HPLC). Bisphosphorylated EF-2 gave 
two phosphopeptides A and B (Fig. 3C), although the 
relative proportions of these species varied in different 
digests. Higher doses of trypsin gave a higher propor- 
tion of A (not shown). 
The tryptic phosphopeptides were also analysed by 
reverse-phase chromatography on a CIs column. 
Monophosphorylated EF.2 gave a single major 
phosphopeptide corresponding to peptide C on two- 
dimensional maps (Fig. 3E). Bisphosphorylated eEF-2 
gave two peaks of radioactivity, eluting slightly earlier 
than peptide C and corresponding topeptides A and B 
seen on two-dimensional maps (Fig. 319. 
3.3. Identification of phosphorylated residues 
Peptide C was found to have the sequence Phe-Thr- 
Asp-Thr-Arg- on gas-phase sequencing. All the 
radioactivity was released after the third cycle of the 
degradation ( ot shown), Also, treatment of peptide C 
with the Asp-N proteinase resulted in ~ts complete con- 
version to a phosphopeptide which, unlike peptide C 
itself, migrated towards the anode at pH 3.6 (Fig. 3D). 
This confirmed that all the radioactivity was associated 
with the first threonine in the sequence. Peptide C 
therefore has the sequence shown in Table I. 
Since digests of bisphosphorylated eEF-2 contain on- 
ly peptides A and B, and no peptide C, the sequences of
these peptides must contain that of peptide C. the only 
phosphopeptide obtained from monophosphorylated 
eEF-2. Thus, A and B must represent variants contain- 
ing the sequence -Phe-Thr(P)S6-Asp-ThrSa-Arg-. The 
additional phosphothreonine r sidue could then be 
threonine-58 (present in peptide C). Alternatively A and 
B may correspond to peptides extended at the C- and/or 
N-terminus compared with peptide C. In the latter case 
they might start, for example, at alanine-50 (resulting 
from tryptic cleavage at arginine-a9), and thus include 
threonine-53. However, during the Edman degradation 
of peptides A and B, 55% and 52%, respectively, of the 
32P-radioactivity was released after 3 cycles thus ex- 
cluding the possibility that A and B were Noterminal e×- 
tensions of peptide C starting at alanine-50 (or beyond) 
and phosphorylated at threonine-53 (since no radioac- 
tivity would then have been released after cycle three). 
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Fig, 3. Analysis of phospltopeptides from phosphorylated eEF.2 
Panel A: bisphosphorylated eEF-2 was subjected to digestion witl~ 
CNBr and the resulting fragments were analysed on a Trieine SDS- 
polyucrylamide gel. The positions of molecular mass markers are 
shown (values in kDa). The figure shews an autoradiograph of the 
fixed gel, Panels B and C: the products of tryptic digestion of eEF-2 
previously cleaved by CNBr were analysed by two.dimensional mapp- 
ing (elcctrophoresis at pH 3,6 and chromatography, see section 2 for 
details), The positions of peptides A, B and C are indicated where ap- 
propriate and the origin is marked by an open circle, and the migra. 
tion of the dinitrophenyllysine marker by the open square., The direc- 
tions of electrophoresis and chromatography (arrow) are also in- 
dicated. Tl~e figures are autoradiographs of the resulting maps, 
Panels B and C show peptides from monophosphorylated and 
bisphosphorylated eEF-2 respectively, Panel D: peptide C was 
digested witl~ the Asp-N protemase from P, fragi and the products 
were analysed by two-dimensional mapping, Panels E and F: Analysis 
cf tryptic fragments from phosphorylated eEF-2 by reverse-phase 
chromatography, Tryptic fragments from a mixture of mono- (Panel 
E) and bisphosphorylated (Panel F) eEF-2 were applied to the C ~s col. 
umn which was developed with a gradient of increasing concentra- 
tions of acetonitrile as indicated (flow rate 1 ml rain" ~), The frac- 
tions (0.5 ml) were counted for ~2p radioactivity, The positions of 
peaks referred to as A, B and C are indicated. 
Essential ly all the radioact iv i ty (93°7o and 96°70 for  pep- 
tides A and B respectively) was released after 5 cycles in- 
dicat ing that they must  represent the two possible 
b isphosphory lated variants o f  pept ide C, 
phosphory lated  at threonines-56 and -58. They  must 
presumably di f fer at their C-termini .  It is l ikely that B 
contains an addit ional  ysine which would be consistent 
Volume Ill2. number 2 FEBS LETTERS May 1991 
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Fig, 4, Mappin[t or phosphopeptidcs from rabbit reticulocyte EF.2 
pllosphc~rylated in situ, Tryptic phosphopcptides were analysed by 
two.d!menfionnl ma ppins, The poshtons of peptides correspondinB 
to ~ak~ A, B and C (Fill, 3} are indicated. The figure is annotated as 
rot Fill, 3. Ponds B and C, 
sent in the lysat¢, and that phosphorylatlon occurs at 
the same sites as those identified in vitro. After com- 
pletion of our work, Ovchinnikov et al, [30] reported 
that. in vitro, threonine 53 was phosphorylated In addi- 
tion to residues 56 and 58. However, we have no 
evidence for significant phosphorylatton of more than 
the two sites described here either in vitro or in 
reticulocyte lysates under any condition tested, 
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